This study tests new medicine for people with HIV, which is the virus that causes AIDS. The medicines are called long-acting (LA) Cabotegravir (CAB) and Rilpivirine (RPV). They are different from regular pills because they work longer and are given as injections. The study will check how well these medicines work for people whose current HIV medicine is not helping enough.

• The study lasts about 6 months, and you will need to visit the clinic often.
• Participants must be aged 12 or older and meet certain health criteria.
• There are risks like reactions to injections, and you must not be pregnant.

If you join, you will need to follow the study rules and might be asked about your experience with the treatment. You cannot join if you have certain health problems like liver disease or if you are on certain medications. This study hopes to find a better way to treat HIV, making it easier for people to manage their health.